Anandamide, 1st Edition,Gerald Litwack,ISBN9780123747822
Add to Wish List
 
 
 
Multi-Volume: Vitamins and Hormones

Volume 81: Anandamide, 1st Edition

Print Book

Editor in Chief : G Litwack  

Release Date:

Imprint: Academic Press

ISBN: 9780123747822

Pages: 536

Dimensions: 229 X 152

Buy print & eBook together
and save 40%

GBP 128.00
Print Book

+

GBP 124.00
eBook

GBP 252.00Normal price

GBP 151.20Bundle price

Add to Cart

Print Book Estimated Delivery Time

Hardcover

GBP 128.00
GBP 64.00

In Stock

eBook eBook Overview

GBP 124.00
GBP 62.00

PDF format

VST format

ePUB format

Add to Cart

Buy Print & eBook both and save 40%
View Bundle Price

 
 

Gerald Litwack

Trained in biochemistry at the University of Wisconsin, Madison, Dr. Litwack worked on enzymology and the effects of hormones on enzyme systems. Then he was a Postdoctoral Fellow of the National Foundation for Infantile Paralysis at the Biochemical Institute of the Sorbonne in Paris. Dr. Litwack's first position was as Assistant Professor of Biochemistry at Rutgers University in 1954. Six years later, he joined the University of Pennsylvania as associate professor and four years later went to the Fels Institute for Cancer Research and Molecular Biology, as full professor, eventually becoming Deputy Director of the Institute. In 1991, he accepted the Chair of Pharmacology at Thomas Jefferson University where he is also Deputy Director of the Jefferson Cancer Institute and Associate Director for Basic Science in the Jefferson Cancer Center. Dr. Litwack's work has been in the area of mechanisms of steroid receptor action involving especially the glucocorticoid and mineralocorticoid receptors, immunophi.

Affiliations and Expertise

Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA, USA

View additional works by Gerald Litwack

Anandamide, 1st Edition

Table of Contents

Y. Okamoto, K. Tsuboi and N. Ueda, Enzymatic formation of anandamide

M.L. Yates and E.L. Barker, Organized trafficking of anandamide and related lipids

G.P. Mueller and W.J. Driscoll, Biosynthesis of oleamide

C.E. Goodfellow and M. Glass, Anandamide receptor signal transduction

A.J. Brown and C.R. Hiley, Is GPR55 an anandamide receptor?

E. Fride, N. Gobshtis, H. Dahan, A. Weller, A. Giuffrida and S. Ben-Shabat, The endocannabinoid system during development; emphasis on perinatal events and delayed effects

M. Bifulco, A. Santoro, C. Laezza and A.M. Malfitano, Cannabinoid receptor CB1 antagonists: state of the art and challenges

H.B. Bradshaw, N. Rimmerman, S.S.-J. Hu, S. Burstein and the late J.M. Walker, Novel endogenous N-acyl glycines: Identification and characterization

F.G. Correa, L. Mestre, F. Docagne, J. Borrell and C. Guaza, The endocannabinoid anandamide: from immunomodulation to neuroprotection, implications for multiple sclerosis

P. Grimaldi, G. Rossi, G. Catanzaro and M. Maccarrone, Modulation of the endocannabinoid-degrading enzyme fatty acid amide hydrolase by follicle-stimulating hormone

R. Malcher-Lopes and M. Buzzi, Glucocorticoid-regulated crosstalk between arachidonic acid and endocannabinoids biochemical pathways coordinates cognitive-, neuroimmune- and energy homeostasis-related adaptations to stress

L. Zhang and W. Xiong, Modulation of the Cys-loop ligand-gated ion channels by fatty acid and cannabinoids

D. McHugh and R.A. Ross, Endogenous cannabinoids and neutrophil chemotaxis

R. Pierantoni, G. Cobellis, R. Meccariello, G. Cacciola, R. Chianese, T. Chioccarelli and S. Fasano, CB1 activity in male reproduction: mammalian and non-mammalian animal models

A. Toth, P.M. Blumberg and J. Boczan, Anandamide and the vanilloid receptor (TRPV1)

L.B.M. Resstel, F.A. Moreira and F.S. Guimaraes, Endocannabinoid system and fear conditioning

N. Pasquariello, S. Oddi, M. Malaponti and M. Maccarrone, Regulation of gene transcription and keratinocyte differentiation by anandamide

G. Alpini and S. DeMorrow, Changes in the endocannabinoid system may give insight into new and effective treatments for cancer

R. Panday, V. Hegde, N. Singh, L. Hofseth, U. Singh, S. Ray, M. Nagarkatti and P. Nagarkatti, Use of cannabinoids as a novel therapeutic modality against autoimmune hepatitis

»
Anandamide